20.10.2021 • News

Milliken Completes Acquisition of Encapsys

US chemical producer Milliken has completed the acquisition of compatriot Encapsys from the Cypress Performance Group (CPG), a holding company formed by Sherman Capital Holdings in the merger of Encapsys with IPS Corporation.

Milliken’s management said the acquisition brings a unique combination of innovation, science and technology to the South Carolina-headquartered company. Coupled with Milliken’s ability to scale, the deal is expected to “propel efforts to deliver sustainable innovations.”

Appleton, Wisconsin-based Encapsys is regarded as a leading player in microencapsulation technologies, which put a uniform polymeric shell around a core material at the micron level to create capsules. These are leveraged by companies to achieve more sustainable products by advancing responsible consumption and efficient delivery of active materials, as Milliken explained.

As Encapsys is integrated into Milliken, the companies said daily operations will continue without interruption, including relationships with existing suppliers and customers.

Author: Dede Williams, Freelance Journalist

Milliken has completed the acquisition of compatriot Encapsys from the Cypress...
Milliken has completed the acquisition of compatriot Encapsys from the Cypress Performance Group. The Wisconsin firm is a leading player in microencapsulation technologies, which put a uniform polymeric shell around a core material at the micron level to create capsules. © AVAVA/Shutterstock

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read